• share
• favorite_border

The new medical director for the UC Davis Comprehensive Cancer Center Office of Clinical Research is Dr. Edward Kim who steps into his new position e on July 1, 2021.

• share
• favorite_border

The UC Davis Clinical Translational Science Center (CTSC) received notice of its third National Institutes of Health (NIH) award renewal. The 5-year award, almost $33 million, provides critical funding to continue CTSC’s essential services for the UC Davis research community.

• share
• favorite_border

A new study shows that two-thirds of Californians don’t know about a law designed to prevent a person at risk of hurting themselves or others from possessing or purchasing firearms or ammunition. More than 80% of survey participants were supportive once they read about this law.

• share
• favorite_border

An international team of researchers, led by UC Davis Health, developed a new therapeutic approach to treating psoriatic arthritis, a chronic inflammatory disease affecting the joints.

• share
• favorite_border

UC Davis Comprehensive Cancer Center researchers found that targeting androgen receptors - a type of protein specific to men - may destroy cancer cells. Focusing on this male protein variant common in malignant bladder tumor cells may serve as a new avenue for treating bladder cancer in men.

• share
• favorite_border

UC Davis researchers develop PsychLight, a sensor that could be used in discovering new treatments for mental illness, in neuroscience research and to detect drugs of abuse.

• share
• favorite_border

A partnership between UC Davis and Maurice J. Gallagher, Jr., chairman and CEO of Allegiant Travel Company, has led to a 20-minute COVID-19 test. The method pairs a mass spectrometer with a powerful machine-learning platform to detect SARS-CoV-2 in nasal swabs. A recent study published in Nature Scientific Reports shows the test to be 98.3% accurate for positive COVID-19 tests and 96% for negative tests.

• share
• favorite_border

A new study, conducted by three UC Davis Comprehensive Cancer Center researchers, studies young adult smoking trends three years after the start of California’s law raising the sales age of tobacco to 21.

• share
• favorite_border

In one of the largest research projects of its kind, a new study published in JAMA Network Open looks at nearly 900,000 individuals and close to 2 million mammograms to come up with a new way to detect the most breast cancer cases with the fewest exams.

• share
• favorite_border

UC Davis Health researchers studying executive control in adolescents and young adults with autism have published new research that suggests a unique approach, rather than impairment.

• share
• favorite_border

The UC Davis MIND Institute and the National Fragile X Foundation have launched an international registry of people carrying the fragile X premutation. The goal is to facilitate and encourage research about the genetic condition to improve understanding and treatment.

• share
• favorite_border

UC Davis MIND Institute researchers used machine learning to crunch 10,000 autoantibody pattern combinations to identify maternal biomarkers associated with a sub-type of autism. The findings have implications for early diagnosis and intervention.

• share
• favorite_border

A survey of Californians finds that exposure to violence has pervasive social and emotional impacts on people, especially when firearms are involved.

• share
• favorite_border

Wildfire smoke contains microbes, infectious agents that might cause diseases. In a perspective piece published in Science, researchers at UC Davis Health and the University of Idaho proposed a multidisciplinary approach to study the health impacts of microbes carried by wildfire smokes.

• share
• favorite_border

Researchers found that a long-accepted theory about brain size in some children with autism may not be true. In a separate study, they linked development of white matter with changes in autism symptom severity.

• share
• favorite_border

An enzyme in the colon lining releases hydrogen peroxide – a known disinfecting compound- to protect the body from gut microbial communities. Findings from the UC Davis Health study points to importance of considering a different approach to treating gut inflammation and bacterial imbalance in the colon.

• share
• favorite_border

UC Davis Health will launch a COVID-19 clinical trial with Novavax to test a new coronavirus vaccine. This vaccine has an important advantage: liquid state storage that allows for distribution using standard vaccine channels, unlike the Pfizer and Moderna vaccines that must be stored at subzero temperature.

• share
• favorite_border

A new study by the UC Davis MIND Institute finds a connection between gestational age and ADHD in children with Down syndrome. An earlier gestational age is linked to higher ADHD symptoms later in childhood.

• share
• favorite_border

In a case series of three teen patients, UC Davis Health pediatricians present the common manifestations of COVID-19 and lung injury due to vaping (EVALI). As EVALI and COVID-19 share many symptoms, it is critical for health providers to get the vaping history of teenagers with unexplained breathing problems.

• share
• favorite_border

Adolescent and young adult (AYA) patients treated for acute myeloid leukemia (AML) have a high risk of developing several long-term health complications after treatment, a study led by UC Davis Comprehensive Cancer Center researchers has found. The most common complications were cardiovascular, endocrine and respiratory diseases. The complications - known as late effects - were more present among non-white AYA patients and those living in more deprived neighborhoods.